Flow diagram of participants meeting the inclusion and exclusion criteria. by Yeo Ju Sohn (18536198)

Subjects:

Initial participants by wave*. by Yeo Ju Sohn (18536198)

Subjects:

These files contain the STATA program codes used in the study. by Yeo Ju Sohn (18536198)

Subjects:

Generalized estimating equation model covariance structure analysis. by Yeo Ju Sohn (18536198)

Subjects:

Raw dataset collected from the KLoSA from 2006 to 2020. by Yeo Ju Sohn (18536198)

Subjects:

General characteristics of research participants. by Yeo Ju Sohn (18536198)

Subjects:

Generalized estimation equation model analysis of diabetes mellitus incidence according to relative handgrip strength. by Yeo Ju Sohn (18536198)

Subjects:

Trends analysis in diabetes mellitus diagnosis according to relative handgrip strength. by Yeo Ju Sohn (18536198)

Subjects:

Genomic downregulation of TGF β1 production in monocytes obtained after RZV administration. Panel A. The heatmap shows 16 genes on the y axis whose accessibility significantly chan... by Michael J. Johnson (5818168)

Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

Blood test data. by Yasuaki Mushiga (21485741)

“…</p><p>Conclusions</p><p>Macular retinal volumes may decrease owing to DM and elevated serum lipid levels. …”

Characteristic of the eyes. by Yasuaki Mushiga (21485741)

“…</p><p>Conclusions</p><p>Macular retinal volumes may decrease owing to DM and elevated serum lipid levels. …”

Raw data of the participants. by Yasuaki Mushiga (21485741)

“…</p><p>Conclusions</p><p>Macular retinal volumes may decrease owing to DM and elevated serum lipid levels. …”

Estimated coefficients from the SARIMA model of new COVID-19 deaths assuming a gradual effect following the implementation of two ETSs and one executive order in Oregon. by Raul Cruz-Cano (3751321)

Subjects:

Trends in COVID-19 deaths in Oregon, for both the overall population and by agricultural worker type, between March 1, 2020 and February 27, 2021. by Raul Cruz-Cano (3751321)

Subjects:

Correlation between the 7-day rolling average of estimated new daily COVID-19 cases among agricultural labor groups and the general population in Oregon. by Raul Cruz-Cano (3751321)

Subjects:

Estimated coefficients from the SARIMA model of new COVID-19 cases, assuming an abrupt effect following the implementation of two ETSs and one executive order in Oregon. by Raul Cruz-Cano (3751321)

Subjects:

Trends in COVID-19 cases in Oregon, for both the overall population and by agricultural worker type, between March 1, 2020 and February 27, 2021. by Raul Cruz-Cano (3751321)

Subjects: